The role of nitric oxide generation in interferon-evoked cytochrome P450 down-regulation

被引:22
作者
Hodgson, PD [1 ]
Renton, KW [1 ]
机构
[1] DALHOUSIE UNIV,DEPT PHARMACOL,HALIFAX,NS B3H 4H7,CANADA
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1995年 / 17卷 / 12期
基金
英国医学研究理事会;
关键词
nitric oxide; interferon; cytochrome P450;
D O I
10.1016/0192-0561(95)00083-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The down-regulation of cytochrome P450 during host defence involves one or more mediators of unknown source and identity. Owing to striking similarities in the features that are involved in the production of NO and the features involved in the down-regulation of cytochrome P450 we hypothesized that NO could be a mediator in the interferon-evoked loss of cytochrome P450. In these experiments the nitric oxide synthase inhibitor L-nitroarginine (5 mg/kg) failed to protect mice from the down-regulation of cytochrome P450, ethoxyresorufin dealkylase and para-nitrophenol hydroxylase in the liver following administration of the Interferon inducer polyinosinic polycytidylic acid. A higher dose of L-nitroarginine (30 mg/kg) given every 12 h for 3 days also did not protect against cytochrome P450 losses. In addition, no down-regulation of the enzyme was observed in animals treated with multiple doses of the NO-generating drugs glyceryl trinitrate (16 and 80 mg/kg given every 4 h for 16 h) and nitroprusside (20 and 100 mg/kg given every 4 h for 16 h). These results indicate that the down-regulation of cytochrome P450 by interferon or its inducers probably does nor involve NO as a required intermediary.
引用
收藏
页码:995 / 1000
页数:6
相关论文
共 33 条
[1]  
BURKE MD, 1977, DRUG METAB DISPOS, V5, P1
[2]   NITRIC-OXIDE - A PHYSIOLOGICAL MEDIATOR OF PENILE ERECTION [J].
BURNETT, AL ;
LOWENSTEIN, CJ ;
BREDT, DS ;
CHANG, TSK ;
SNYDER, SH .
SCIENCE, 1992, 257 (5068) :401-403
[3]  
CLARK CJ, 1979, LANCET, V1, P492
[4]  
CRAIG PI, 1990, MOL PHARMACOL, V38, P313
[5]   NITRIC-OXIDE AND NITRIC OXIDE-GENERATING COMPOUNDS INHIBIT HEPATOCYTE PROTEIN-SYNTHESIS [J].
CURRAN, RD ;
FERRARI, FK ;
KISPERT, PH ;
STADLER, J ;
STUEHR, DJ ;
SIMMONS, RL ;
BILLIAR, TR .
FASEB JOURNAL, 1991, 5 (07) :2085-2092
[6]   SUSTAINED HYPERTENSION INDUCED BY ORALLY-ADMINISTERED NITRO-L-ARGININE [J].
DANANBERG, J ;
SIDER, RS ;
GREKIN, RJ .
HYPERTENSION, 1993, 21 (03) :359-363
[7]  
ELDEFRAW.S, 1974, DRUG METAB DISPOS, V2, P267
[8]   EFFECT OF MURINE GAMMA-INTERFERON ON THE MOUSE-LIVER AND ITS DRUG-METABOLIZING-ENZYMES - COMPARISON WITH HUMAN HYBRID ALPHA-INTERFERON [J].
FRANKLIN, MR ;
FINKLE, BS .
JOURNAL OF INTERFERON RESEARCH, 1985, 5 (02) :265-272
[9]   NITRIC-OXIDE - A CYTO-TOXIC ACTIVATED MACROPHAGE EFFECTOR MOLECULE [J].
HIBBS, JB ;
TAINTOR, RR ;
VAVRIN, Z ;
RACHLIN, EM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (01) :87-94
[10]   NITRIC-OXIDE IS A MEDIATOR OF THE DECREASE IN CYTOCHROME-P450-DEPENDENT METABOLISM CAUSED BY IMMUNOSTIMULANTS [J].
KHATSENKO, OG ;
GROSS, SS ;
RIFKIND, AB ;
VANE, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11147-11151